1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Cardiovasculares

Enfermedades Cardiovasculares

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Delgado C, Vázquez M, Oca R, Vilar M, Trinidad C, Sanmartin M.

    Myocardial Ischemia Evaluation With Dual-source Computed Tomography: Comparison With Magnetic Resonance Imaging

    REVISTA ESPANOLA DE CARDIOLOGIA . 66(11): 864-870. Nº de citas: 15

    [doi:10.1016/j.rec.2013.05.026]

  • Ruíz-del-Árbol L, Achécar L, Serradilla R, Rodríguez-Gandía MÁ, Rivero M, Garrido E, Natcher JJ.

    Diastolic Dysfunction Is a Predictor of Poor Outcomes in Patients With Cirrhosis, Portal Hypertension, and a Normal Creatinine

    HEPATOLOGY . 58(5): 1732-1741. Nº de citas: 133

    [doi:10.1002/hep.26509]

  • Dias A, Franco E, Usatii V.

    Stress-induced cardiomyopathy shortly after pacemaker placement.

    JOURNAL OF INVASIVE CARDIOLOGY . 25(11): .

  • Grande E, Kreissl MC, Filetti S, Newbold K, Reinisch W, Robert C, Schlumberger M, Tolstrup LK, Zamorano JL, Capdevila J.

    Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies

    ADVANCES IN THERAPY . 30(11): 945-966. Nº de citas: 52

    [doi:10.1007/s12325-013-0069-5]

  • Rodriguez Muñoz D, Markl M, Moya Mur JL, Barker A, Fernández-Golfín C, Lancellotti P, Zamorano Gómez JL.

    Intracardiac flow visualization: current status and future directions

    European Heart Journal-Cardiovascular Imaging . 14(11): 1029-1038. Nº de citas: 90

    [doi:10.1093/ehjci/jet086]

  • Barrios V, Escobar C.

    Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?

    EXPERT OPINION ON PHARMACOTHERAPY . 14(16): 2249-2261. Nº de citas: 7

    [doi:10.1517/14656566.2013.834887]

  • Calvo M, Subirats L, Ceccaroni L, Maroto JM, de Pablo C, Miralles F.

    Automatic Assessment of Socioeconomic Impact on Cardiac Rehabilitation

    International Journal of Environmental Research and Public Health . 10(11): 5266-5283. Nº de citas: 7

    [doi:10.3390/ijerph10115266]

  • El Assar M, Ruiz de Adana JC, Angulo J, Pindado Martínez ML, Hernández Matías A, Rodríguez-Mañas L.

    Preserved endothelial function in human obesity in the absence of insulin resistance

    Journal of Translational Medicine . 11: 263-263. Nº de citas: 38

    [doi:10.1186/1479-5876-11-263]

  • Brugaletta S, Sabate M, Martin-Yuste V, Masotti M, Shiratori Y, Alvarez-Contreras L, Cequier A, Iñiguez A, Serra A, Hernandez-Antolin R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Gomez-Lara J, Backx B, Serruys PW.

    Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction Insights from the EXAMINATION trial

    International Journal of Cardiology . 168(3): 2632-2636. Nº de citas: 8

    [doi:10.1016/j.ijcard.2013.03.036]

  • Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, García-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández-Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, Pérez de Prado A, Fernández-Campos MJ, Casado I, García-Rubira JC, García-Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández-Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster V.

    Effect of Early Metoprolol on Infarct Size in ST-Segment-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial

    CIRCULATION . 128(14): 1495-1503. Nº de citas: 342

    [doi:10.1161/CIRCULATIONAHA.113.003653]

  • Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL.

    2013 ESC guidelines on the management of stable coronary artery disease

    EUROPEAN HEART JOURNAL . 34(38, SI): 2949-2949. Nº de citas: 3600

    [doi:10.1093/eurheartj/eht296]

  • Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, De Backer G, Sirnes PA, Ezquerra EA, Avogaro A, Badimon L, Baranova E, Baumgartner H, Betteridge J, Ceriello A, Fagard R, Funck-Brentano C, Gulba DC, Hasdai D, Hoes AW, Kjekshus JK, Knuuti J, Kolh P, Lev E, Mueller C, Neyses L, Nilsson PM, Perk J, Ponikowski P, Reiner Z, Sattar N, Schächinger V, Scheen A, Schirmer H, Strömberg A, Sudzhaeva S, Tamargo JL, Viigimaa M, Vlachopoulos C, Xuereb RG.

    ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    EUROPEAN HEART JOURNAL . 34(39, SI): 3035-3035. Nº de citas: 1702

    [doi:10.1093/eurheartj/eht108]

  • de Pablo C, Velasco E.

    Coffee preparation: does it affect our health?

    EUROPEAN HEART JOURNAL . 34(35): 2721-2722.

  • Pison L, Proclemer A, Bongiorni MG, Marinskis G, Hernandez-Madrid A, Blomström-Lundqvist C.

    Imaging techniques in electrophysiology and implantable device procedures: results of the European Heart Rhythm Association survey

    EUROPACE . 15(9): 1333-1336. Nº de citas: 13

    [doi:10.1093/europace/eut259]

  • de Agustin JA, Marcos-Alberca P, Fernández-Golfin C, Feltes G, Nuñez-Gil IJ, Almeria C, Rodrigo JL, Arrazola J, Pérez de Isla L, Macaya C, Zamorano J.

    Should computed tomography coronary angiography be aborted when the calcium score exceeds a certain threshold in patients with chest pain?

    International Journal of Cardiology . 167(5): 2013-2017. Nº de citas: 10

    [doi:10.1016/j.ijcard.2012.05.041]

  • Brignole, M, Zamorano JL.

    2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

    EUROPACE . 15(8): 1070-1118. Nº de citas: 786

    [doi:10.1093/europace/eut206]

  • Cabrera Bueno F, Alzueta Rodríguez J, Olagüe de Ros J, Fernández-Lozano I, García Guerrero JJ, de la Concha JF, Hernández Madrid A, Tolosana Viu JM, Osca Asensi J, Barrera Cordero A, Llorente Hernangómez E.

    Improvement in Hemodynamic Response Using a Quadripolar LV Lead

    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY . 36(8): 963-969. Nº de citas: 4

    [doi:10.1111/pace.12172]

  • Dobreanu D, Svendsen JH, Lewalter T, Hernández-Madrid A, Lip GY, Blomström-Lundqvist C.

    Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey

    EUROPACE . 15(8): 1223-1225. Nº de citas: 34

    [doi:10.1093/europace/eut227]